| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309560 | Clinica Chimica Acta | 2018 | 7 Pages |
Abstract
Our assay can quantify both sub-therapeutic and therapeutic concentrations of bioavailable adalimumab in patient serum samples. This assay design provides an alternative to isotope-labeled peptides approach currently adopted in targeted proteomics methods.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Yifei Yang, Emily Wysocki, Kwasi Antwi, Eric Niederkofler, Edward K.Y. Leung, Eszter Lazar-Molnar, Kiang-Teck J. Yeo,